• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problems Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017)
Patient Problems Red Eye(s) (2038); Eye Pain (4467)
Event Date 11/24/2022
Event Type  Injury  
Event Description
The consumer reported accidental exposure to the binaxnow covid-19 self-test reagent on (b)(6) 2022.Per the consumer, she accidentally mistook the reagent for "dry eye drops" and added a few drops to her eye before realizing her mistake.The consumer reported using a saline eye wash to attempt to remedy the error before calling in.She also reported her eye to be slightly pink and having a burning sensation.The consumer was advised via phone to wash her eye under running water and contact a healthcare provider to ensure that proper treatment is administered.Upon a follow up call later the same day, the consumer stated that she was feeling "much better".
 
Manufacturer Narrative
Technical services provided the safety data sheet to the customer.The remainder of the investigation remains in progress.A supplemental report will be provided after completion.Device discarded, single use.
 
Manufacturer Narrative
A product deficiency was not reported or found.Technical service provided the safety data sheet and advised the consumer to contact their health provider if any irritation occurred.A supplemental report will be provided if any additional information is obtained.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.H3 other text : device discarded, single use.
 
Event Description
The consumer reported accidental exposure to the binaxnow covid-19 self-test reagent on (b)(6) 2022.Per the consumer, she accidentally mistook the reagent for "dry eye drops" and added a few drops to her eye before realizing her mistake.The consumer reported using a saline eye wash to attempt to remedy the error before calling in.She also reported her eye to be slightly pink and having a burning sensation.The consumer was advised via phone to wash her eye under running water and contact a healthcare provider to ensure that proper treatment is administered.Upon a follow up call later the same day, the consumer stated that she was feeling "much better".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key15936133
MDR Text Key305043572
Report Number1221359-2022-10255
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/05/2023
Device Catalogue Number195-160
Device Lot Number207915
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/24/2022
Initial Date FDA Received12/07/2022
Supplement Dates Manufacturer Received02/01/2023
Supplement Dates FDA Received02/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age21 YR
Patient SexFemale
Patient Weight63 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-